QTc interval prolongation in children with Ulrich-Turner syndrome

European Journal of Pediatrics

Volumn 165, Issue 12, 2006, Pages 831-837

  Dalla Pozza, Robert ^a,b   Bechtold, Susanne ^a   Kääb, Stefan ^a   Buckl, Matthias ^a   Urschel, Simon ^a   Netz, Heinrich ^a   Schwarz, Hans Peter ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cardiac malformations; Long QT syndrome; QT interval; Ullrich Turner Syndrome

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTRADIOL VALERATE; GESTAGEN; HUMAN GROWTH HORMONE;

ADOLESCENT; ARTICLE; BODY HEIGHT; CARDIOVASCULAR RISK; CHILD; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; HEART REPOLARIZATION; HUMAN; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; SUDDEN DEATH; TURNER SYNDROME;

BODY MASS INDEX; CASE-CONTROL STUDIES; CHILD; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LONG QT SYNDROME; MALE; RETROSPECTIVE STUDIES; TURNER SYNDROME;

EID: 33750326312     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-006-0194-0     Document Type: Article

References (38)

1. Algra A, Tijssen J, Roelandt J, Pool J, Lubsen J (1991) QTc prolongation measured by standard 12 lead electrocardiogram is an independent risk factor for sudden death. Circulation 83:1888-1894
2. American Academy of Pediatrics (1995) Committee on Genetics Health supervision for children with Turner syndrome. Pediatrics 96:1166-1173
3. Bazett HC (1920) An analysis of the time relations of the electrocardiograms. Heart 7:353-370
4. Bechtold SM, Dalla Pozza R, Becker A, Meidert A, Döhlemann C, Schwarz HP (2004) Partial anomalous pulmonary vein connection: an underestimated cardiovascular defect in Ullrich-Turner syndrome. Eur J Pediatr 163:158-162
5. Chiang CE (2004) Congenital and acquired long QT syndrome. Current concepts and management. Cardiol Rev 12:222-234
6. Crouch MA, Limon L, Cassano AT (2003) Clinical relevance and management of drug-related QT interval prolongation. Pharmacotherapy 23:881-908
7. Davignon A, Rautaharju P, Boisselle E (1979/1980) Normal ECG standards for infants and children. Pediatr Cardiol 1:123-152
8. Fukushige T, Yoshinaga M, Shimago A, Nishi J, Kono Y, Nomura Y, Miyata K, Imamura M, Shibata T, Nagashima M, Niimura I (2002) Effect of age and overweight on the QT interval and the prevalence of long QT syndrome in children. Am J Cardiol 89:395-398
9. Garson A Jr (1993) How to measure the QT interval: what is normal? Am J Cardiol 72:14B-16B
10. Goetzsche C-O, Krag-Olsen B, Nielsen J, Sorensen KE, Kristensen BO (1994) Prevalence of cardiovascular malformations and association with Karyotypes in Turner's syndrome. Arch Dis Child 71:433-436
11. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL (2002) ACC/AHA/NASPE Guideline Update for Implantation of Cardiac Pacemakers and Arrhythmia Devices: Summary Article. J Cardiovasc Electrophysiol 13:1183-1199
12. James AF, Choisy SC, Hancox JC (2005) Recent advances in understanding sex differences in cardiac repolarization. Prog Biophys Mol Biol (e-publication: 13 June 2005) (doi:10.1016/j.pbiomolbiol.2005.05.010)
13. Kääb S, Pfeufer A, Hinterseer M, Nabauer M, Schulze-Bahr E (2004) Long QT syndrome. Why does sex matter? Z Kardiol 93:641-45
14. Li H, Fuentes-Garcia J, Towbin JA (2000) Current concepts in long QT syndrome. Pediatr Cardiol 21:542-550
15. Mazzanti L, Cacciari E (1998) Congenital heart disease in patients with Turner's syndrome. Italian Study group for Turner Syndrome (ISGTS). J Pediatr 133:688-692
16. Molnar J, Weiss J, Zhang F, Rosenthal JE (1996) Evaluation of five QT correction formulas using a software-assisted method of continuous QT measurement from 24-hour holter recordings. Am J Cardiol 78:920-926
17. Moss AJ, Schwartz PJ, Crampton RS, Locati E, Carleen E (1985) The long QT syndrome: a prospective international study. Circulation 71:17-21
18. Moss AJ, Zareba W, Hall WJ, Schwartz PJ, Crampton RS, Benhorin J, Vincent GM, Locati EH, Priori SG, Napolitano C, Medina A, Zhang L, Robinson JL, Timothy K, Towbin JA, Andrews ML (2000) Effectiveness and limitations of beta-blocker therapy in congenital long QT syndrome. Circulation 101:616-623
19. Pearl W (1996) Effects of gender, age, and heart rate on QT intervals in children. Pediatr Cardiol 17:135-136
20. Prader A, Largo RH, Molinari L, Issler C (1989) Physical growth of Swiss children from birth to 20 years of age. 1st Zürich longitudinal study of growth and development. Helv Paediatr Acta 52[Suppl]:1-25
21. Price WH, Lauder IJ, Wilson J (1974) The electrocardiogram and sex chromosome aneuploidy. Clin Genet 6:1-14
22. Ranke MB, Wilton P (1999) Growth hormone therapy in KIGS: 10 years' experience. Barth Verlag, Heidelberg Leipzig
23. Ranke MB, Saenger P (2001) Turner's syndrome. Lancet 358:309-314
24. Roden DM (2004) Drug-induced prolongation of the QT interval. N Engl J Med 350:1013-1022
25. Roden DM, Temple R (2005) The US Food and Drug Administration cardiorenal advisory panel and the drug approval process. Circulation 111:1697-1702
26. Saenger P (1996) Turner's syndrome. N Engl J Med 335:1749-1754
27. Saenger P, Wikland KA, Conway GS, Davenport M, Gravholt CH, Hintz R, Hovatta O, Hultcrantz M, Landin-Wilhelmsen K, Lin A, Lippe B, Pasquino AM, Ranke MB, Rosenfeld R, Silberbach M (2001) Recommendations for the diagnosis and management of Turner syndrome. In: 5th Int Symp Turner Syndrome. J Clin Endocrinol Metab 86:3061-3069
28. Schouten EG, Dekker JM, Meppelimk P, Kolk FJ, Vanderbroucke JP, Pool J (1991) QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation 84:1516-1523
29. Schwartz PJ, Moss AJ, Vincent GM, Crampton RS (1993) Diagnostic criteria for the long QT syndrome: an update. Circulation 88:782-784
30. Schwartz PJ (1997) The long QT syndrome. Curr Prob Cardiol 226:302-351
31. Tanner JM (1962) Growth at adolescence, 2nd edn. Blackwell, Oxford London
32. Vincent GM (1998) The molecular genetic of long QT syndrome: genes causing fainting and sudden death. Annu Rev Med 49 : 263-74
33. Viskin S (1999) Long QT syndromes and torsade de pointes (Seminar). Lancet 354:1625-33
34. Webster R, Leishman D, Walker D (2002) Towards a drug concentration effect relationship for QT prolongation and torsades de pointes. Curr Opin Drug Discov Dev 5:116-126
35. http://www.qtdrugs.org
36. Yap YG, Camm AJ (2003) Drug induced QT prolongation and torsades de pointes. Heart 89:1363-1372
37. Zareba W, Moss AJ (2001) Long QT syndrome in children. J Electrocardiol 34(Suppl):167-171
38. Zareba W, Moss AJ, Daubert JP, Hall WJ, Robinson JL, Andrews M (2003) Implantable cardioverter defibrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol 14:337-341